May 1st 2024
A recent meta-analysis drew limited conclusions about the impact of 1-night sleep restriction on cognitive function, stressing the need for further research consideration.
The Promising Role of Novel and Emerging Therapies for Amyotrophic Lateral Sclerosis: Clinical and Managed Care Insights
1.0 Credit / Neurology
View More
Evolving Treatment Strategies in the Management of Pulmonary Arterial Hypertension: Key Insights for the Pharmacist, featuring a Patient Perspective
1.5 Credits / Pulmonology/Respiratory
View More
Advances in EGFR Exon 20 Insertion-Positive Non–Small Cell Lung Cancer: A Focus on Specialty Pharmacy Interventions
1.5 Credits / Oncology, Pulmonology/Respiratory
View More
Strategies for the Management and Treatment of ALS: The Value of Early Diagnosis and Clinical Intervention
3.0 Credits / Neurology
View More
Advancing Targeted Therapies Aimed at Smoldering Disease in Multiple Sclerosis
June 27, 2024 | 1:00 & 7:00 PM EDT
View More
Leveraging Managed Care to Optimize Best Practices in the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
1.0 Credit / Neurology
View More
Advances and Best Practices for Managed Care Pharmacists and the Treatment of Patients with Alpha-1 Antitrypsin Deficiency
1.0 Credit / Pulmonology/Respiratory
View More
Improving Outcomes and Quality of Care in Spinal Muscular Atrophy: Updates in Treatment Advances
2.0 Credits / Neurology
View More
New and Emerging Treatment Strategies for Myasthenia Gravis: The Role of the Specialty Pharmacist
1.0 Credit / Neurology
View More
Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Caregiver Burden
1.5 Credits / Neurology
View More
Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care
1.5 Credits / Neurology
View More
Regular Bedtimes for Toddlers Linked to Less Obesity Later, Study Finds
April 25th 2017Research over the past decade has found connections between poor sleep and obesity, but this is the first study to examine the connections among bedtimes in young children, emotional self-regulation, and obesity later in life.
Read More
Night Shift Workers With Diabetes Tend to Have Poorer Glycemic Control
April 7th 2017Research presented this week at the 99th annual meeting of the Endocrine Society suggested that people with type 2 diabetes who worked overnight shifts tend to have poorer control over their blood sugar levels than those who worked during the day or were unemployed.
Read More
What We're Reading: Medicaid Caretaker Fraud Leaves Patients Suffering
November 7th 2016What we’re reading, November 7, 2016: caretaker fraud within Medicaid’s Personal Care Services program left patients neglected and abused; a proposal to increase shift limits for first-year residents from 16 to 28 hours draws both support and criticism; CDC has identified 13 locally-acquired cases of antibiotic-resistant Candida auris in the US.
Read More
What We're Reading: AAP Issues Sleep Safety Recommendations for Infants
October 26th 2016What we’re reading, October 26, 2016: AAP advises that parents take measures to reduce the risk of SIDS; Republican presidential nominee Donald Trump reacts to ACA premium hikes announced by HHS; patients with ALS volunteer for an accelerated study on the effects of a dietary supplement.
Read More
Restless Legs Syndrome/Willis-Ekbom Disease Diagnostic Criteria: Why Change?
June 6th 2013In this session, Daniel Picchietti, MD, discussed changes to the diagnostic guidelines for restless legs syndrome/Willis-Ekbom disease published jointly by the International Restless Legs Syndrome Study Group and the National Institutes of Health.
Read More
Managing Restless Leg Syndrome: Current Strategies and Treatment Guidelines
June 6th 2013In this session, Stephany Fulda, PhD, discussed the common causes of restless leg syndrome (RLS), considerations for the clinical application of treatment strategies for RLS, and changes to treatment guidelines for RLS that may be on the horizon.
Read More
Sleep and Sleep Disorders: Comorbid Conditions and Pathophysiology
June 4th 2013Dr Thomas Roth, PhD, presented on the evolution of our understanding of insomnia, and the importance of insomnia in the context of other disease states. Roth noted that insomnia is primarily a disorder of increased wakefulness from a pathophysiologic standpoint, and presented data to support this. Presenting the effect of improved sleep on diseases such as depression, worker productivity, and cardiovascular disease, Roth revealed rich prospects for the future of sleep medicine in treating a variety of disorders.
Read More
Dr Sharon Discusses How Insurers Have Responded to the Availability of Therapies for RLS
June 4th 2013In this video, Denise Sharon, MD, PhD, Clinical Director and Founding Partner, Comprehensive Sleep Medicine Center of the Gulf Coast, discusses how insurers have responded to the availability of therapies and changes in clinical practice guidelines for RLS.
Read More
Sleepiness in a 24/7 World with Dr. Hans Van Dongen, PhD
June 3rd 2013In this presentation, Dr. Van Dongen discussed the pharmacology of various treatments for sleep disturbance associated with shift work. Dr. Van Dongen discussed the issues associated with use of medications to improve the alertness of sleepy workers.
Read More
Dr Jennifer Martin Talks About the Effectiveness of Cognitive Behavioral Treatment for Insomnia
June 3rd 2013In this video, Jennifer Martin, PhD, Assistant Professor, UCLA, David School of Medicine, discusses how the effectiveness of cognitive behavioral treatment for insomnia among patients with dementia compare with current pharmacologic strategies.
Read More
Dr Jennifer Martin Discusses How Insomnia Has Evolved & Affects In Insurance Coverage
June 2nd 2013In this video, Jennifer Martin, PhD, Assistant Professor, UCLA, David School of Medicine, shares her thoughts on how non-pharmacologic treatments for the management of insomnia has evolved over the past few years and how the increased use of behavioral treatments might affect insurance coverage.
Read More
Epilepsy and Sleep: Defining the Relationship
June 2nd 2013Sleep disorders are common in patients with epilepsy; approximately 70% of patients with epilepsy experience problems with sleep. In his presentation, Dr Erik St. Louis discussed the impact of sleep on seizures, as well as the effects of comorbid sleep disorders on epilepsy.
Read More
The NIH: Opportunities in the Digital Age
June 2nd 2013In his presentation, Gary H. Gibbons, MD, director of the National Heart, Lung, and Blood Institute at the National Institutes of Health, described the functions of his organization and discussed the potential for improvements in the understanding of disease states in the digital age.
Read More